Imbalance between serum matrix metalloproteinase-9 and its inhibitor is associated with increased airway wall thickness in uncontrolled asthmatics

A. Mohamed-Hussein, S. Abdel-Azis (Assiut, Egypt)

Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Session: Mechanisms of asthma and lung inflammation
Session type: E-Communication Session
Number: 1738
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mohamed-Hussein, S. Abdel-Azis (Assiut, Egypt). Imbalance between serum matrix metalloproteinase-9 and its inhibitor is associated with increased airway wall thickness in uncontrolled asthmatics. Eur Respir J 2010; 36: Suppl. 54, 1738

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Source: Eur Respir J 2005; 25: 885-890
Year: 2005



Sputum matrix metalloproteinase-9 and tissue inhibitor of matrix metalloprotienase-1 levels in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006

Relationship between sputum level of matrix metallopreteinase (MMP-9)/tissue inhibitor of metalloproteinase (TIMP-1) and methacholine bronchial hyper-reactivity in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002

Increased concentration of matrix metalloproteinase-9 in serum of COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17A in mouse airways
Source: Annual Congress 2004 - Insights into asthma and COPD
Year: 2004


Extracellular matrix components and regulators in the airway smooth muscle in asthma
Source: Eur Respir J 2008; 32: 61-69
Year: 2008



Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

Matrix metalloproteinase-8 deletion promotes allergen-induced airway inflammation in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 659s
Year: 2004

The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004

Effect of theophylline on matrix metalloproteinase-9 in induced sputum in the elderly patients with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003

Elevation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in healthy smokers
Source: Eur Respir J 2005; 26: Suppl. 49, 105s
Year: 2005

Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone
Source: Eur Respir J 2004; 24: 107-115
Year: 2004



ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo
Source: Eur Respir J 2002; 20: 170-176
Year: 2002



Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 328s
Year: 2005

Matrix metalloproteinase inhibitor inhibits lipopolysaccharide-induced goblet-cell hyperplasia in rat airway
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002

Could concentration of matrix metalloproteinase-9 in serum of COPD patients change into the basic disease progress and a degree of airway obstruction?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Source: Eur Respir J 2009; 33: 77-84
Year: 2009



Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Source: Eur Respir J 2008; 32: 644-650
Year: 2008